ICMR to test
efficacy of two medicines for tackling drug-resistant TB
New Delhi: The
Indian Council of Medical Research (ICMR) is planning to test the efficacy of
two medicines — Metformin and Bedaquiline Delaminate — for tackling the
drug-resistant tuberculosis.
Metformin is
widely used to treat type-II diabetes. ICMR now plans a clinical trial to
examine its effectiveness in fighting the TB microbe following encouraging
scientific results from Indian biologists, reports Deccan Herald.
Bedaquiline, which received the US
Food and Drug Administration’s approval in 2012 for the treatment of
drug-resistant TB cases, is yet to be used in India’s public-funded national TB
control programme.
The Metformin trial is expected to
start in a couple of months, while the Bedaquiline trial may take about six
months to kick off, according to ICMR director general Dr Soumya Swaminathan.
17.05.2017
Most people fail in life because they major in minor things
Anthony Robbins
No comments:
Post a Comment